AU2002224940A1 - Use of carbohydrates for eliminating intestinal infections in animals - Google Patents

Use of carbohydrates for eliminating intestinal infections in animals

Info

Publication number
AU2002224940A1
AU2002224940A1 AU2002224940A AU2002224940A AU2002224940A1 AU 2002224940 A1 AU2002224940 A1 AU 2002224940A1 AU 2002224940 A AU2002224940 A AU 2002224940A AU 2002224940 A AU2002224940 A AU 2002224940A AU 2002224940 A1 AU2002224940 A1 AU 2002224940A1
Authority
AU
Australia
Prior art keywords
pathogenic bacteria
carbohydrates
intestinal
inhibit
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224940A
Inventor
Michael Klingeberg
Gunhild Kozianowski
Markwart Kunz
Mohammad Munir
Manfred Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suedzucker AG
Original Assignee
Suedzucker AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suedzucker AG filed Critical Suedzucker AG
Publication of AU2002224940A1 publication Critical patent/AU2002224940A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Feed For Specific Animals (AREA)

Abstract

The use of carbohydrates (I) is claimed as active agents for treating intestinal infections in animals, where (I) is not degradable by enzymes in the digestive tract, is other than lactulose and is selected from oligosaccharides, oligosaccharide derivatives, hydrolyzates of polymeric carbohydrates and their mixtures. An independent claim is also included for animal feedstuffs (specifically dietetic feedstuffs) containing (I). ACTIVITY : Antibacterial; Virucide; Fungicide; Antiparasitic; Antiinflammatory; Antidiarrheic; Analgesic; Antiemetic; Antipyretic. MECHANISM OF ACTION : Improvement of condition of bacterial flora; Prevention of deposition and adhesion of pathogenic bacteria on the intestinal epithelium. Some (I) are fermented by the intestinal flora to give lower fatty acids (especially butyric acid), lactic acid and/or acetic acid, which reduce the pH in the large intestine, promote growth of non-pathogenic bacteria and inhibit growth of pathogenic bacteria. Some (I) inhibit deposition of pathogenic bacteria on the intestinal epithelium or block the fimbriae of pathogenic bacteria to inhibit adhesion to the intestinal epithelium.
AU2002224940A 2001-01-31 2001-12-17 Use of carbohydrates for eliminating intestinal infections in animals Abandoned AU2002224940A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10104055A DE10104055A1 (en) 2001-01-31 2001-01-31 Use of carbohydrates to eliminate intestinal infections in animals
DE10104055.5 2001-01-31
PCT/EP2001/014867 WO2002060452A2 (en) 2001-01-31 2001-12-17 Use of carbohydrates for eliminating intestinal infections in animals

Publications (1)

Publication Number Publication Date
AU2002224940A1 true AU2002224940A1 (en) 2002-08-12

Family

ID=7672177

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224940A Abandoned AU2002224940A1 (en) 2001-01-31 2001-12-17 Use of carbohydrates for eliminating intestinal infections in animals

Country Status (8)

Country Link
EP (3) EP1698341A3 (en)
AT (1) ATE366578T1 (en)
AU (1) AU2002224940A1 (en)
DE (2) DE10104055A1 (en)
DK (1) DK1357917T3 (en)
ES (1) ES2290195T3 (en)
PT (1) PT1357917E (en)
WO (1) WO2002060452A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10147100A1 (en) * 2001-09-25 2003-04-17 Numico Res B V Anti-infective carbohydrates
DE10226203B4 (en) * 2002-06-13 2008-04-03 Südzucker AG Mannheim/Ochsenfurt Condensed Palatinose, process for its preparation and its use
DE10242062B4 (en) * 2002-09-11 2007-02-15 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Hydrogenated condensed Palatinose, process for their preparation and their use
DE10328180A1 (en) * 2003-06-16 2005-01-13 Südzucker AG Mannheim/Ochsenfurt Use of isomalt as prebiotic
EP1745705A1 (en) * 2005-07-20 2007-01-24 N.V. Nutricia Process for preparing uronic acid oligosaccharides by extrusion
JP5270144B2 (en) * 2007-12-18 2013-08-21 サンエイ糖化株式会社 Use of maltobionic acid, its salt or maltobiono delta lactone-containing composition
DE102013022109A1 (en) * 2013-12-27 2015-07-02 Markus Paulmichl Oligo- (2-7) -glucuronate-containing drug (second medical indication)
MX2021005374A (en) * 2018-11-08 2021-09-14 Dsm Ip Assets Bv Methods of supporting gastrointestinal homeostasis.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0616680B2 (en) * 1986-07-17 1994-03-09 昭和産業株式会社 Animal feed
JPH0661222B2 (en) * 1986-07-18 1994-08-17 昭和産業株式会社 Animal feed
GB2206582B (en) * 1987-06-04 1991-02-13 Mitsui Sugar Co Palatinose condensation product and a process for the preparation thereof and a method for utilizing the product
DE3733899A1 (en) * 1987-10-07 1989-06-15 Teichmann Reinhard Prof Dr Med Products and methods for increasing growth rate and/or utilisation of food or nutrients and/or resistance in animals and humans
JPH01211529A (en) * 1988-02-19 1989-08-24 Tomoji Tanaka Drug containing chitin or chitosan compound as base material
JPH06205669A (en) * 1992-08-04 1994-07-26 Aomori Pref Gov Selective proliferating agent and selective bacteriostatic agent for microbe
JP4127864B2 (en) * 1994-09-29 2008-07-30 太陽化学株式会社 Gram-negative bacterial growth inhibitor
US5688777A (en) * 1995-04-05 1997-11-18 Abbott Laboratories Inhibition of C. difficile infections by indigestible oligosaccharides
US5733579A (en) * 1995-04-05 1998-03-31 Abbott Laboratories Oral rehydration solution containing indigestible oligosaccharides
US5925190A (en) * 1995-06-06 1999-07-20 The University Of Montana Production of fructose dianhydride products from inulin
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
US5939279A (en) * 1997-09-18 1999-08-17 The Board Of Trustees Of The University Of Arkansas Inhibition of bacterial binding by high-mannose oligosaccharides
US6126961A (en) * 1998-04-13 2000-10-03 Kross; Robert D. Composition and method for reducing the colonization of animal intestines by salmonella and other bacterial pathogens
DE19818842C1 (en) * 1998-04-28 2000-01-05 Suedzucker Ag Cold remedy containing sugar alcohol mixture such as Isomalt, having immunostimulant and antimicrobial activity
IT1307850B1 (en) * 1999-03-15 2001-11-19 Italmed Di Galli Giovanna E Pa PHARMACEUTICAL COMPOSITION BASED ON LACTIC FERMENTS AND NON-ABSORBABLE CARBOHYDRATIN CONTAINING A CALCIUM SALT AND AN ALUMINUM SALT
AU779710C (en) * 2000-03-10 2005-07-21 Mars, Incorporated Treatment of infection in animals
DE10057976B4 (en) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Process for the preparation of pectin hydrolysis products

Also Published As

Publication number Publication date
WO2002060452A3 (en) 2003-03-20
DE10104055A1 (en) 2002-08-14
EP1698341A2 (en) 2006-09-06
ES2290195T3 (en) 2008-02-16
EP1357917B9 (en) 2008-03-05
WO2002060452A2 (en) 2002-08-08
DE50112727D1 (en) 2007-08-23
ATE366578T1 (en) 2007-08-15
EP1357917A2 (en) 2003-11-05
EP1698341A3 (en) 2006-09-20
EP1698342A1 (en) 2006-09-06
DK1357917T3 (en) 2007-11-05
EP1357917B1 (en) 2007-07-11
PT1357917E (en) 2007-10-11

Similar Documents

Publication Publication Date Title
EP0623022B1 (en) Formulation and use of microorganisms in treating livestock
US3957974A (en) Method for deodorization of excrements
US5266315A (en) Composite for Clostridium difficile diarrhea and pseudomembranous colitis
Mertens et al. Halophilic, lactose-positive Vibrio in a case of fatal septicemia
US4767623A (en) Method of binding microflora and preparations therefor
CN1390135A (en) Topical treatment of streptococcal infections
WO2000010582A8 (en) Probiotic, lactic acid-producing bacteria and uses thereof
Mårdh et al. In vitro interactions between lactobacilli and other microorganisms occurring in the vaginal flora
MX9708793A (en) Bacterial treatment for silage.
JPH06500700A (en) Long-term antimicrobial activity achieved by sustained release of hydrogen peroxide
AU2002224940A1 (en) Use of carbohydrates for eliminating intestinal infections in animals
US6630458B2 (en) Teat dipping agent
WO2013009910A2 (en) Eosinophil peroxidase compositions and methods of their use
AU3555800A (en) Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
Kuroda et al. FR-900130, a novel amino acid antibiotic I. discovery, taxonomy, isolation, and properties
KR100430298B1 (en) Microorganism preparation complex for using feed additives or treating animal sewage
Ejlertsen et al. Pasteurella aerogenes isolated from ulcers or wounds in humans with occupational exposure to pigs: a report of 7 Danish cases
CN1679968A (en) Medical supersonic conductive gel
EP0521166A4 (en) Lactic acid bacterium starter, containing peroxidase, fermented milk product, and production thereof
JP2002507123A (en) Method for improving the effectiveness of probiotics, preparation of nutritional additives and animal feed containing same
JPH02191205A (en) Biologically active composition
CN116158493A (en) Feed additive for livestock
FR2380277A1 (en) Antibacterial beta-lactam antibiotic - desacetyl-di:hydro-890A9 prepd. by enzymatic de:acetylation of di:hydro-890A9 and used e.g. as pharmaceutical or feed additive (NL 15.8.78)
JPH06145066A (en) Medical composition for enhancement of effect of chemotherapeutic agent and for prevention and improvement of infectious disease
JP2007189947A (en) Inhibitor of hydrogen sulfide-producing bacterium and method for inhibiting hydrogen sulfide-producing bacterium

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase